[1] |
Bouvier F,Rahier A,Camara B.Biogenesis,molecular regulation and function of plant isoprenoids[J].Prog. Lipid Res.,2005,44(6):357-429
|
[2] |
Ajikumar P K,Tyo K,Carlsen S,Mucha O,Phon T H,Stephanopoulos G.Terpenoids:opportunities for biosynthesis of natural product drugs using engineered microorganisms[J].Mol.Pharm.,2008,5(2):167-190
|
[3] |
Chang M C,Keasling J D.Production of isoprenoid pharmaceuticals by engineered microbes[J].Nat. Chem. Biol.,2006,2:674-681
|
[4] |
Liu Duo(刘夺),Du Jin(杜瑾),Zhao Guangrong(赵广荣),Yuan Yingjin(元英进).Applications of synthetic biology in medicine and energy[J].CIESC Journal(化工学报),2011,62(9):2391-2397
|
[5] |
Ro D K,Ouellet M,Paradise E M,Burd H,Eng D,Paddon C J,Newman J D,Keasling J D.Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor,artemisinic acid[J].BMC Biotechnol.,2008,8:83
|
[6] |
Ro D K,Paradise E M,Ouellet M,Fisher K J,Newman K L,Ndungu J M,Ho K A,Eachus R A,Ham T S,Kirby J,Chang M C,Withers S T,Shiba Y,Sarpong R,Keasling J D.Production of the antimalarial drug precursor artemisinic acid in engineered yeast[J].Nature,2006,440:940-943
|
[7] |
Huang Q L,Roessner C A,Croteau R,Scott A I. Engineering Escherichia coli for the synthesis of taxadiene,a key intermediate in the biosynthesis of taxol[J].Bioorg.Med.Chem.,2001,9(9):2237-2242
|
[8] |
Newman J D,Marshall J,Chang M,Nowroozi F,Paradise E,Pitera D,Newman K L,Keasling J D.High-level production of amorpha-4,11-diene in a two-phase partitioning bioreactor of metabolically engineered Escherichia coli[J].Biotechnol.Bioeng.,2006,95(4):684-691
|
[9] |
Zhou Y J,Gao W,Rong Q X,Jin G J,Chu H Y,Liu W J,Yang W,Zhu Z W,Li G H,Zhu G F,Huang L Q,Zhao Z B.Modular pathway engineering of diterpenoid synthases and the mevalonic acid pathway for miltiradiene production[J].J.Am.Chem.Soc.,2012,134(6):3234-3241
|
[10] |
Engels B,Dahm P,Jennewein S.Metabolic engineering of taxadiene biosynthesis in yeast as a first step towards taxol(paclitaxel)production[J].Metabol.Eng.,2008,10(3/4):201-206
|
[11] |
Dai Z B,Liu Y,Huang L Q,Zhang X L.Production of miltiradiene by metabolically engineered Saccharomyces cerevisiae[J].Biotechnol.Bioeng.,2012,109(11):2845-2853
|
[12] |
Ajikumar P K,Xiao W H,Tyo K E,Wang Y,Simeon F,Leonard E,Mucha O,Phon T H,Pfeifer B,Stephanopoulos G.Isoprenoid pathway optimization for taxol precursor overproduction in Escherichia coli[J].Science,2010,330(6000):69-74
|
[13] |
Carter O,Peters R J,Croteau R.Monoterpene biosynthesis pathway construction in Escherichia coli[J].Phytochemistry,2003,64(2):425-433
|
[14] |
Urban A,Neukirchen S,Jaeger K E.A rapid and efficient method for site-directed mutagenesis using one-step overlap extension PCR[J].Nucleic Acids Res.,1997,25(11):2227-2228
|
[15] |
Young L,Dong Q H.Two-step total gene synthesis method[J].Nucleic Acids Res.,2004,32(7):e59
|
[16] |
Jiang Y,Proteau P,Poulter D,Novick S F.BTS1 encodes a geranylgeranyl diphosphate synthase in Saccharomyces cerevisiae[J].J.Biol.Chem.,1995,270:21793-21799
|
[17] |
Asadollahi M A,Maury J,Schalk M,Clark A,Nielsen J.Enhancement of farnesyl diphosphate pool as direct precursor of sesquiterpenes through metabolic engineering of the mevalonate pathway in Saccharomyces cerevisiae[J].Biotechnol.Bioeng.,2010,106(1):86-96
|
[18] |
Donald K A,Hampton R Y,Fritz I B.Effects of overproduction of the catalytic domain of 3-hydroxy-3-methylglutaryl coenzyme A reductase on squalene synthesis in Saccharomyces cerevisiae[J].Appl. Environ. Microbiol.,1997,63(9):3341-3344
|
[19] |
Narum D L,Kumar S,Rogers W O,Fuhrmann S R,Liang H,Oakley M,Taye A,Sim B K,Hoffman S L. Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice[J].Infect. Immun.,2001,69(12):7250
|
[20] |
Siddiqui M S,Thodey K,Trenchard I,Smolke C D. Advancing secondary metabolite biosynthetic in yeast with synthetic biology tools[J].FEMS Yeast Res.,2012,12:144-170
|